Initial Experience with the Use of Intravenous Eptifibatide Bolus during Endovascular Treatment of Intracranial Aneurysms

References

1. ↵
   ISAT Collaborative Group. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. Lancet 2002;360:1267–74

   CrossRefPubMedWeb of Science
2. ↵
   Park HK, Horowitz MB, Jungries C, et al. Periprocedural morbidity and mortality associated with endovascular treatment of intracranial aneurysms. AJNR Am J Neuroradiol 2005;26:506–14

   Abstract/FREE Full Text
3. ↵
   Cronqvist M, Pierot L, Boulin A, et al. Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: a comparison of anatomic and clinical outcome. AJNR Am J Neuroradiol 1998;19:157–65

   Abstract
4. ↵
   Pelz DM, Lownie SP, Fox AJ. Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. AJNR Am J Neuroradiol 1998;19:1541–47

   Abstract
5. Fourie P, Duncan IC. Microsnare-assisted mechanical removal of intraprocedural distal middle cerebral arterial thromboembolism. AJNR Am J Neuroradiol 2003;24:630–32

   Abstract/FREE Full Text
6. ↵
   Derdeyn CP, Cross III DT, Moran C, et al. Postoperative ischemic events after treatment of intracranial aneurysms with Guglielmi detachable coils. J Neurosurg 2002;96:837–43

   PubMedWeb of Science
7. Koebbe CJ, Horowitz MB, Levy EI, et al. Intraarterial thrombolysis for thromboemboli associated with endovascular aneurysm coiling. Interv Neuroradiol 2002;8:151–58
8. ↵
   Ng PP, Phatouros CC, Khangure MS. Use of glycoprotein IIb-IIIa inhibitor for a thromboembolic complication during Guglielmi detachable coil treatment of an acutely ruptured aneurysm. AJNR Am J Neuroradiol 2001;22:1761–63

   Abstract/FREE Full Text
9. Cloft HJ, Samuels OB, Tong FC, et al. Use of abciximab for mediation of thromboembolic complications of endovascular therapy. AJNR Am J Neuroradiol 2001;22:1764–67

   Abstract/FREE Full Text
10. ↵
    Kwon OK, Lee KJ, Han MH, et al. Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases. AJNR Am J Neuroradiol 2002;23:447–51

    Abstract/FREE Full Text
11. ↵
    Alexander MJ, Duckwiler GR, Gobin YP, et al. Management of intraprocedural arterial thrombus in cerebral aneurysm embolization with abciximab: technical case report. Neurosurgery 2002;50:899–902

    CrossRefPubMedWeb of Science
12. Workman MJ, Cloft HJ, Tong FC, et al. Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol 2002;23:1568–76

    Abstract/FREE Full Text
13. Mounayer C, Piotin M, Baldi S, et al. Intraarterial administration of abciximab for thromboembolic events occurring during aneurysm coil placement. AJNR Am J Neuroradiol 2003;24:2039–43

    Abstract/FREE Full Text
14. Bendok BR, Padalino DJ, Levy EI, et al. Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization: case report and literature review. Surg Neurol 2004;62:304–11

    CrossRefPubMedWeb of Science
15. ↵
    Song JK, Niimi Y, Fernandez PM, et al. Thrombus formation during intracranial aneurysm coil placement: treatment with intra-arterial abciximab. AJNR Am J Neuroradiol 2004;25:1147–53

    Abstract/FREE Full Text
16. ↵
    Benitez RP, Silva MT, Klem J, et al. Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils. Neurosurgery 2004;54:1359–67

    CrossRefPubMedWeb of Science
17. ↵
    Fiorella D, Albuquerque FC, Han P, et al. Preliminary experience using the Neuroform stent for the treatment of cerebral aneurysms. Neurosurgery 2004;54:6–16

    CrossRefPubMedWeb of Science
18. ↵
    Soeda A, Sakai N, Sakai H, et al. Thromboembolic events associated with Guglielmi detachable coil embolization of asymptomatic cerebral aneurysms: evaluation of 66 consecutive cases with use of diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2003;24:127–32

    Abstract/FREE Full Text
19. ↵
    Bavinzski G, Talazoglu V, Killer M, et al. Gross and microscopic histopathological findings in aneurysms of the human brain treated with Guglielmi detachable coils. J Neurosurg 1999;91:284–93

    PubMed
20. ↵
    Malisch TW, Giglielmi G, Vinuela, et al. Intracranial aneurysms treated with Guglielmi detachable coil: midterm clinical results in a consecutive series of 100 patients. J Neurosurg 1997;87:176–83

    PubMedWeb of Science
21. ↵
    Klotzsch C, Nahser HC, Henkes H, et al. Detection of microemboli distal to cerebral aneurysms before and after therapeutic embolization. AJNR Am J Neuroradiol 1998;19:1315–18

    Abstract
22. ↵
    Raymond J, Guilbert F, Metcalfe A, et al. Role of endothelial lining in recurrences after coil embolization: prevention of recanalization by endothelial denudation. Stroke 2004;35:1471–75

    Abstract/FREE Full Text
23. ↵
    Vinuela F, Duckwiler G, Mawad M. Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 1997;86:475–82

    PubMedWeb of Science
24. ↵
    Rechavia E, Wurzel M. Platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction associated with thrombotic occlusion of the left main coronary artery. Circulation 1998;98:1249–50

    FREE Full Text
25. ↵
    Mascelli MA, Lance ET, Damaraju L, et al. Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GPIIb-IIIa receptor blockade. Circulation 1998;97:1680–88

    Abstract/FREE Full Text
26. ↵
    Li YF, Spencer FA, Becker RC. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition. Am Heart J 2002;143:725–32

    CrossRefPubMedWeb of Science
27. ↵
    Dasgupta H, Blankenship JC, Wood GC, et al. Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis. Am Heart J 2000;140:206–11

    CrossRefPubMedWeb of Science
28. ↵
    Scarborough RM. Development of eptifibatide. Am Heart J 1999;138:1093–104

    CrossRefPubMedWeb of Science